Clinical Trials Directory

Trials / Completed

CompletedNCT00956033

Skin Biopsies in Chemotherapy-Induced Neuropathy

Skin Biopsies in Chemotherapy-induced Neuropathy

Status
Completed
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Neuropathy is a common side effect of chemotherapeutics used for the treatment of multiple myeloma, including vincristine, thalidomide and bortezomib. The neuropathy induced by these drugs is often preferentially small fiber. Small fiber neuropathies are difficult to diagnose and quantify using conventional electromyography. Determining intra-epidermal nerve fiber density (IENFD) in skin biopsies from diabetes and AIDS patients has been shown to be a more sensitive and more specific ancillary investigation to establish the diagnosis of small fiber neuropathy. In this study the investigators aim to establish the sensitivity of IENFD measurements in skin biopsies from patients with multiple myeloma treated with bortezomib.

Conditions

Timeline

Start date
2008-11-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2009-08-11
Last updated
2014-12-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00956033. Inclusion in this directory is not an endorsement.